OpenResearchAlpha

bioRxiv · 18 Nov 2026

In the non-canonical NF-κB pathway, binding of the initiating kinase NIK to the pathway's target, p100, serves a nonenzymatic "licensing" role

Xun Liangh-index 2, David Scheerer, Konstantin Bogdanov, Mike Gardarsky, Chaitanyakumar Amballa, Tianzhen Wang, David Morgenstern, Moshe Goldsmith, Dana Reichmann, Gilad Haran, David Wallachh-index 3

0
Citations
no database records one yet
0
Citations in 2026
so far
3
Leading author's h-index
David Wallach, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

The non-canonical NF-{kappa}B pathway plays pivotal roles in adaptive immunity. It is initiated by NIK-mediated phosphorylation of IKK1, which phosphorylates p100 and promotes processing of newly synthesized p100. However, IKK1 can also be activated by other kinases to mediate distinct functions. Why IKK1-induced p100 processing occurs efficiently downstream of NIK but not of other kinases is unknown. Here, we show that whereas pre-existing p100 can be phosphorylated by IKK1 without NIK, phosphorylation of newly synthesized p100 critically depends on additional non-enzymatic functions of NIK's C-terminal portion. NIK binds IKK1 and restrains its kinase activity, while its binding to p100 enhances p100 phosphorylation. Single-molecule FRET spectroscopy and XL-MS revealed that the C-terminal region of p100 adopts a folded-back conformation and undergoes structural rearrangement upon NIK binding, likely accounting for this enhancement. Thus, NIK not only initiates the pathway but also dictates its specificity through binding to its downstream substrate.

Molecular biology

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • David Wallach has the highest h-index among the authors (3).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (11)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.
In the non-canonical NF-κB pathway, binding of the initiating kinase NIK to the pathway's target, p100, serves a nonenzymatic "licensing" role - QAI OpenResearch